Tobias Larsson Agervald
Directeur Général chez GUARD THERAPEUTICS INTERNATIONAL AB
Provenance du réseau au premier degré de Tobias Larsson Agervald
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 13 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Tobias Larsson Agervald via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| University of Gothenburg | College/University | Doctorate Degree Graduate Degree Doctorate Degree | |
| Stockholm School of Economics | College/University | Graduate Degree Graduate Degree Masters Business Admin | |
| DEVYSER DIAGNOSTICS AB | Medical Specialties | Director/Board Member Director/Board Member | |
| COREM PROPERTY GROUP AB | Real Estate Development | Chairman Director/Board Member | |
| SCANDI STANDARD AB (PUBL) | Food: Meat/Fish/Dairy | Chairman Director/Board Member | |
| NOBINA AB (PUBL) | Other Transportation | Chairman Corporate Officer/Principal | |
| ONCOPEPTIDES AB | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
| University of Lund | College/University | Undergraduate Degree Undergraduate Degree | |
| University of Uppsala | College/University | Graduate Degree Undergraduate Degree | |
Preelumina AB
 Preelumina AB Pharmaceuticals: MajorHealth Technology PrePreelumina AB develops pharmaceutical products for diagnosis of preeclampsia. The firm investigates the mechanisms behind the development of preeclampsia and identified a unique treatment method based on an endogenous protein. The company was founded by Tomas Jörgen Eriksson in 2008 and is headquartered in Lund, Sweden. | Pharmaceuticals: Major | Chief Executive Officer | |
Gambro AB
 Gambro AB Medical SpecialtiesHealth Technology Gambro AB engages in the development and manufacturing of dialysis equipment and blood purification products. It provides products and therapies for kidney and liver dialysis, myeloma kidney therapy, and other extracorporeal therapies for chronic and acute patients. The firm offers products for hemodialysis, acute care, myeloma kidney therapy, and vascular access and water systems. The company was founded by Holger Crafoord in 1964 and is headquartered in Lund, Sweden. | Medical Specialties | Corporate Officer/Principal | |
Nordic Bioscience A/S
 Nordic Bioscience A/S Miscellaneous Commercial ServicesCommercial Services Nordic Bioscience A/S engages in preclinical and clinical drug development. It specializes in precision medicine using biomarker technologies. The company was founded by Claus Henrik Christiansen and Bente Juel Riis in 1991 and is headquartered in Herlev, Denmark. | Miscellaneous Commercial Services | Sales & Marketing | |
| ENORAMA PHARMA AB | Pharmaceuticals: Major | Director/Board Member | |
WC Likvid AB
 WC Likvid AB Real Estate DevelopmentFinance WC Likvid AB owns and manages movable and immovable property. The company was founded by Tadeusz Wojciech Wieloch on June 5, 2009 and is headquartered in Staffanstorp, Sweden. | Real Estate Development | Director/Board Member | |
Finja Five AB
 Finja Five AB Information Technology ServicesTechnology Services Finja Five AB develops and manages the concept child-friendly-computing (CFC) for schools and at home. It operates as a knowledge enterprise within the business segment of information and communication technology (ICT). The firm’s main business is CFC for emerging markets, globally. The company was founded in 2008 and is headquartered in Lund, Sweden. | Information Technology Services | Director/Board Member | |
| Preelumina Diagnostics AB | Chief Executive Officer | ||
| Kombinator Affärsutveckling AB | Director/Board Member | ||
AnaCardio AB
 AnaCardio AB Pharmaceuticals: MajorHealth Technology AnaCardio AB is a clinical stage biopharmaceutical company based in Stockholm, Sweden. AnaCardio develops drugs targeting a novel mechanism that improves cardiac contractility to treat heart failure, a progressive cardiac syndrome affecting more than six million individuals in the US and nearly 100 million worldwide. The Swedish company's unique solution is based on the ghrelin signaling pathway, intended to increase contractility without causing adverse tachycardia, arrhythmia, ischemia, or hypotension. The company was founded by Lars Lund and is currently led by CEO Patrik Strömberg since 2021. | Pharmaceuticals: Major | Director/Board Member | |
Recipharm OT Chemistry AB
 Recipharm OT Chemistry AB Pharmaceuticals: MajorHealth Technology Part of Recipharm AB, Recipharm OT Chemistry AB develops and manufactures drug dosage forms and inhalation products & devices. The company is based in Uppsala, Sweden. | Pharmaceuticals: Major | Corporate Officer/Principal | |
OnTarget Chemistry AB
 OnTarget Chemistry AB BiotechnologyHealth Technology Part of Recipharm AB, OnTarget Chemistry AB provides research services for medicinal synthesis and pharmaceutical products. The company is based in Uppsala, Sweden. OnTarget Chemistry was acquired by Recipharm AB on June 15, 2015 for $1.85 million. | Biotechnology | Chief Executive Officer | |
Industrifonden
 Industrifonden Investment ManagersFinance Industrifonden is a Venture Capital firm, a subsidiary of Government of Sweden founded in 1979. The firm is headquartered in Stockholm. | Investment Managers | Private Equity Investor | |
Immuneed AB
 Immuneed AB Medical SpecialtiesHealth Technology Immuneed AB develops drugs. The firm offers as a contract research organization and provides specialized services for immunotoxicology and immunophenotyping. Its services include cytokine release assay, complement activation, cellular drug biodistribution, cell activation patterns, immune recall responses, viability analyses, blood status and mode-of-action studies. The company was founded by Sara Mangsbo, Erika Fletcher and Thomas Totterman in 2014 and is headquartered in Uppsala, Sweden. | Medical Specialties | Director/Board Member | |
| OT Pharmaceuticals AB | Chief Executive Officer | ||
EpiEndo Pharmaceuticals ehf
 EpiEndo Pharmaceuticals ehf BiotechnologyHealth Technology EpiEndo Pharmaceuticals ehf is a clinical-stage biopharmaceutical company based in Reykjavik, Iceland. The Icelander company focuses on enhancing epithelial barrier integrity to treat inflammatory disorders, with a primary focus on chronic respiratory diseases. The company recently appointed Dr. Kate Hanrott as Director of Clinical Operations and Sciences, bringing extensive experience to the role. EpiEndo Pharmaceuticals will be attending the Bio International Convention in June 2023. EpiEndo Pharmaceuticals was founded in 2014 by Fridrik Gardarsson, and Maria Bech has been the CEO of the company since 2021. | Biotechnology | Chief Executive Officer | |
| SPRINT BIOSCIENCE AB | Pharmaceuticals: Major | Director/Board Member | |
| Synartro AB | Chairman | ||
OT Lehmann Holding AB
 OT Lehmann Holding AB Investment Banks/BrokersFinance OT Lehmann Holding AB provides securities and property management services. The private company is based in Stockholm, Sweden. | Investment Banks/Brokers | Director/Board Member | |
Akinion Pharmaceuticals AB
 Akinion Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Akinion Pharmaceuticals AB operates as a holding company that focuses on the development of pharmaceutical for the treatment of acute myeloid leukemia. It develops, markets, and sells a product based on Biovitrum’s anti leukemia kinase inhibitor research. It is a drug development that manufactures a lead candidate drug, AKN-028, which is a small molecule kinase inhibitor. The company was founded by Vendela Parrow in 2009 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Director/Board Member | |
| University of Adelaide | College/University | Investor Relations Contact | |
| Kabigen AB | Investor Relations Contact | ||
| Actinova AB | Director/Board Member | ||
Active Biotech Research AB
 Active Biotech Research AB Pharmaceuticals: MajorHealth Technology Active Biotech Research AB develops pharmaceuticals. The private company is based in Lund, Sweden. | Pharmaceuticals: Major | Director/Board Member | |
Magle AB
 Magle AB Chemicals: Major DiversifiedProcess Industries Part of Maria Magle Holding AB, Magle AB is a Swedish company that manufactures chemical products. The company is based in Lund, Sweden. | Chemicals: Major Diversified | Sales & Marketing | |
Merozyne Therapeutics AB
 Merozyne Therapeutics AB Pharmaceuticals: MajorHealth Technology Merozyne Therapeutics AB develops and manufactures pharmaceutical products. The company was founded Madeleine Durbeej-Hjalt and Virginie Carmignac and is headquartered in Lund, Sweden. | Pharmaceuticals: Major | Chairman | |
| CANTARGIA AB | Pharmaceuticals: Major | Chief Executive Officer | |
| Gårdarike Fastigheter AB | Director/Board Member | ||
| Karolinska Institutet | College/University | Graduate Degree | |
Quickspin AB
 Quickspin AB Packaged SoftwareTechnology Services Quickspin AB engages in the operation of game studio that develops video slots for online gambling. Its portfolio includes Mayana, Fairy Gate, Sticky Bandits, Wins of Fortune, Gragon Shrine, Hot Sync, Second Strike, and Genies Touch. The company was founded by Daniel Lindberg, Mats Westerlund, and Joachim Timmermans in 2011 and is headquartered in Stockholm, Sweden. | Packaged Software | Director of Finance/CFO | |
| Metynex Pharmaceuticals AB | Director/Board Member | ||
| LIPIGON PHARMACEUTICALS AB | Pharmaceuticals: Major | Director/Board Member | |
| Antaros Holding AB | Director/Board Member | ||
| Antaros Renostic AB | Chairman | ||
Antaros Medical AB
 Antaros Medical AB Miscellaneous Commercial ServicesCommercial Services Antaros Medical AB provides scientific, technical, research and development services. The private company is based in Stockholm, Sweden. The Swedish company was founded by Johannes Hulthe. Johannes Hulthe has been the CEO since incorporation. | Miscellaneous Commercial Services | Founder | |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Sybo invest AB
 Sybo invest AB Miscellaneous Commercial ServicesCommercial Services Sybo Invest AB is a private company based in Oskarshamn, Sweden. The Swedish company specializes in various areas such as saddlery, sewing car interiors, cat breeding, and car fittings. The company is known for their expertise in these fields, particularly in their Sybo Sadelmakeri, Sybo Kattuppfödning, Sybo Bilinredningar, and Sybo Maine Coon divisions. | Miscellaneous Commercial Services | Director/Board Member | |
| Matting Holding AB | Director/Board Member | ||
Matting AB
 Matting AB Home FurnishingsConsumer Durables Matting AB supplies carpets for shops, offices, public environments, and industry. It offers entrance mats, workplace mats, and tactile joints and rugs for dog sports arenas. The firm also provides lightning. The company was founded in 1970 and is headquartered in Alingsas, Sweden. | Home Furnishings | Director/Board Member |
Statistiques
Internationale
| Suède | 48 |
| Danemark | 2 |
| Islande | 2 |
| Australie | 2 |
Sectorielle
| Health Technology | 20 |
| Consumer Services | 7 |
| Finance | 5 |
| Commercial Services | 5 |
| Technology Services | 3 |
Opérationnelle
| Director/Board Member | 82 |
| Independent Dir/Board Member | 22 |
| Chairman | 19 |
| Corporate Officer/Principal | 17 |
| Chief Executive Officer | 11 |
Relations les plus connectées
- Bourse
- Insiders
- Tobias Larsson Agervald
- Connexions Sociétés
